Prolonged release exenatide gets the go-ahead from NICE
Food insecurity: what does it mean to people with diabetes?
There is no such thing as a community diabetologist
Timing of insulin bolus in patients with type 1 diabetes: effect on glucose control and variability using CGMS
Clinical use of C-peptide and β-cell specific autoantibodies during gestational diabetes mellitus
Diabetic renal disease in older people
Exploring factors influencing non-attendance at the diabetes clinic and service improvement strategies from patients' perspectives
Renewal of driving licences and long duration insulin-treated diabetes: a comparison of medical assessment and self-reporting by drivers
Staged diabetes management.
Dabigatran
Does HbA1c have a role as a diagnostic tool in gestational diabetes mellitus (GDM)?
Impact of expansion of the Diabetes InPatient Prospective Service (DIPPS), Portsmouth, into the orthopaedic stream
Metformin therapy and assessment for vitamin B12 deficiency: is it necessary?
Postnatal blood sugar assessment of patients with gestational diabetes mellitus
Using Turning Technologies' TurningPoint to assess FY1 doctors' confidence and ability when recognising correct/incorrect insulin regimens
Primary biliary cirrhosis presenting with profound hypercholesterolaemia requiring plasmapheresis
The development of a hyperglycaemia management pathway to safely reduce hospital admissions
Exenatide can achieve significant weight loss in steroid induced diabetes
Management of hyperglycaemia in acute myocardial infarction (MI) in diabetic patients
The Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits
Factors associated with HbA1c and weight changes at 6 months in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audit